au.\*:("BENNETT, L. L. JR")
Results 1 to 8 of 8
Selection :
Mode of action of 2-amino-6-chloro-1-deazapurineBENNETT, L. L. JR; SMITHERS, D; ROSE, L. M et al.Biochemical pharmacology. 1984, Vol 33, Num 2, pp 261-271, issn 0006-2952Article
A new isotopic assay for purine nucleoside phosphorylaseCHI-HSIUNG CHANG; BENNETT, L. L. JR; BROCKMAN, R. W et al.Analytical biochemistry. 1989, Vol 183, Num 2, pp 279-282, issn 0003-2697Article
Alterations in nucleotide pools induced by 3-deazaadenosine and related compounds: role of adenylate deaminaseBENNETT, L. L. JR; BROCKMAN, R. W; ALLAN, P. W et al.Biochemical pharmacology. 1988, Vol 37, Num 7, pp 1233-1244, issn 0006-2952Article
Inhibition of utilization of hypoxanthine and guanine in cells treated with the carbocyclic analog of adenosine: phosphates of carbocyclic nucleoside analogs as inhibitors of hypoxanthine (guanine) phosphoribosyltransferaseBENNETT, L. L. JR; BROCKMAN, R. W; ROSE, L. M et al.Molecular pharmacology. 1985, Vol 27, Num 6, pp 666-675, issn 0026-895XArticle
Differences in the metabolism and metabolic effects of the carbocyclic adenosine analogs, neplanocin A and aristeromycinBENNETT, L. L. JR; ALLAN, P. W; ROSE, L. M et al.Molecular pharmacology. 1986, Vol 29, Num 4, pp 383-390, issn 0026-895XArticle
Evidence that the carbocyclic analog of adenosine has different mechanisms of cytotoxicity to cells with adenosine kinase activity and to cells lacking this enzymeBENNETT, L. L. JR; BOWDON, B. J; ALLAN, P. W et al.Biochemical pharmacology. 1986, Vol 35, Num 22, pp 4106-4109, issn 0006-2952Article
Synthesis and biochemical properties of 8-amino-6-fluoro-9-β-D-ribofuranosyl-9H-purineSECRIST, J. A. III; BENNETT, L. L. JR; ALLAN, P. W et al.Journal of medicinal chemistry (Print). 1986, Vol 29, Num 10, pp 2069-2074, issn 0022-2623Article
